minocycline inhibits cytochrome c release delays progression amyotrophic lateral sclerosis mice
minocycline mediates neuroprotection experimental models neurodegeneration inhibits activity- caspase- caspase- inducible form nitric oxide synthetase inos p38 mitogen-activated protein kinase mapk although minocycline directly inhibit enzymes effects may result interference upstream mechanisms resulting secondary activation above-mentioned factors important amyotrophic lateral sclerosis als tested minocycline mice als- report minocycline delays disease onset extends survival als mice given broad efficacy minocycline understanding mechanisms action great importance find minocycline inhibits mitochondrial permeability-transition-mediated cytochrome c release minocycline-mediated inhibition cytochrome c release demonstrated vivo cells isolated mitochondria understanding mechanism action minocycline will assist development testing powerful effective analogues safety record minocycline ability penetrate blood-brain barrier drug may novel therapy als
